| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Philip Liang last filed a Form 4 in May 2023, as Director at RBOT. Philip Liang's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Philip Liang a below-average insider score of 45/100, based on 32 past trades. Over a 12-month horizon, 37.5% of those trades were profitable, with an average 12-month return of -27.3%.
At the last filing, the largest reported position was 730,332 shares of RBOT. Net of sales, the RBOT filings show accumulation of 557,332 shares.
Philip Liang has 45 Form 4 filings on record from November 2021 to May 2023, all as Director at Vicarious Surgical (RBOT), 2021–2023.
The 56 reported transactions were 20 open-market purchases, 15 other transactions, 12 open-market sales and 9 stock awards.
Counted by filing, the open-market trades come to 19 purchases worth about $1.8M and 9 sales worth about $713K.
The largest open-market purchase was 79,009 shares of RBOT at an average $3.05 on February 8, 2023, about $241K. Twelve months later RBOT was down 86%.
The largest open-market sale was 44,200 shares of RBOT at an average $3.81 on May 13, 2022, about $169K. Twelve months later RBOT was down 49%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 7,000 | $1.99 | $13,958.00 | +1.0% | -57.4% | -85.7% | |
| Apr 11, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 17,002 | $2.26 | $38,407.52 | +2.4% | -25.2% | -86.3% | |
| Apr 10, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 5,925 | $2.20 | $13,035.00 | New | -19.5% | -84.6% | |
| Apr 6, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 3,000 | $2.05 | $6,150.00 | +0.4% | -11.3% | -87.1% | |
| Mar 28, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 74,300 | $2.32 | $172,227.40 | +11.9% | -21.7% | -87.3% | |
| Mar 27, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 73,900 | $2.07 | $152,973.00 | +13.5% | -22.4% | -86.2% | |
| Mar 24, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 60,125 | $1.65 | $99,146.13 | +12.3% | +7.4% | -82.0% | |
| Mar 23, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 73,500 | $1.71 | $125,538.00 | +17.7% | +33.3% | -77.2% | |
| Mar 13, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 59,100 | $2.36 | $139,366.35 | +16.6% | -9.7% | -85.9% | |
| Mar 9, 2023 | RBOT Vicarious Surgical Inc. | Director | Buy | 37,100 | $2.50 | $92,623.86 | +11.6% | -5.3% | -85.5% |